{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:42:17Z","timestamp":1773657737495,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.neuropharm.2004.12.001","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T07:26:37Z","timestamp":1110525997000},"page":"732-742","source":"Crossref","is-referenced-by-count":25,"title":["CCK-8 prevents the development of kindling and regulates the GABA and NPY expression in the hippocampus of pentylenetetrazole (PTZ)-treated adult rats"],"prefix":"10.1016","volume":"48","author":[{"given":"Paola","family":"Tirassa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Aloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2004.12.001_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1532-0456(00)00175-7","article-title":"A possible interaction between CCKergic and GABAergic systems in the rat brain","volume":"128","author":"Acosta","year":"2001","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-3956(96)00041-6","article-title":"Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics","volume":"31","author":"Bachus","year":"1997","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4615-1335-3_19","article-title":"Neuroprotective strategies in epilepsy","volume":"497","author":"Carlen","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0149-7634(98)00011-6","article-title":"CCK in anxiety and cognitive processes","volume":"22","author":"Dauge","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1460-9568.1998.00033.x","article-title":"Suppression of kindling epileptogenesis in rats by intrahippocampal cholinergic grafts","volume":"10","author":"Ferencz","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1528-1157.2003.51402.x","article-title":"Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice","volume":"44","author":"Fetissov","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj1150465","article-title":"Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities","volume":"115","author":"Fonnum","year":"1969","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0091-3057(01)00612-8","article-title":"Morphological alterations of neurons and astrocytes and changes in emotional behavior in pentylenetetrazol-kindled rats","volume":"70","author":"Franke","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0924-977X(94)00134-W","article-title":"Pentylenetetrazole kindling impairs long-term memory in rats","volume":"5","author":"Genkova-Papazova","year":"1995","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0924-977X(96)00032-6","article-title":"Piracetam and fipexide prevent PTZ-kindling-provoked amnesia in rats","volume":"6","author":"Genkova-Papazova","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(92)91316-7","article-title":"Activation of the dentate gyrus by pentylenetetrazol evoked seizures induces mossy fiber synaptic reorganization","volume":"593","author":"Golarai","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib13","first-page":"425","article-title":"Effects of antisense glutamic acid decarboxylase oligodeoxynucleotide on epileptic rats induced by pentylenetetrazol","volume":"115","author":"He","year":"2002","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2004.12.001_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0143-4179(91)90081-S","article-title":"Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues","volume":"19","author":"Hokfelt","year":"1991","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0920-1211(91)90036-F","article-title":"Alterations in cholecystokinin peptide and mRNA in actively epileptic human temporal cortical foci","volume":"8","author":"Iadarola","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90234-5","article-title":"Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy","volume":"495","author":"de Lanerolle","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0143-4179(95)90082-9","article-title":"Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors","volume":"28","author":"Legido","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF01273363","article-title":"Cholecystokinin peptides and receptor binding in Alzheimer's disease","volume":"103","author":"Lofberg","year":"1996","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0730-725X(95)02014-K","article-title":"Hippocampal MRI volumetrics and temporal lobe substrates in medial temporal lobe epilepsy","volume":"13","author":"Luby","year":"1995","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00019052-199704000-00009","article-title":"Mechanisms of action of new antiepileptic drugs","volume":"10","author":"Macdonald","year":"1997","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/00001756-200106130-00022","article-title":"Cholecystokinin-8 promotes recovery of sympathectomy induced by 6-hydroxydopamine in adult mice","volume":"12","author":"Manni","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.bjp.0703088","article-title":"Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit","volume":"129","author":"Manni","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/rheumatology\/41.7.787","article-title":"Role of cholecystokinin-8 in nerve growth factor and nerve growth factor mRNA expression in carrageenan-induced joint inflammation in adult rats","volume":"41","author":"Manni","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib23","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1523\/JNEUROSCI.15-05-03990.1995","article-title":"Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata","volume":"15","author":"Mathern","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib24","first-page":"1","article-title":"Neurobiology of cholecystokinin","volume":"9","author":"Moran","year":"1994","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib25","first-page":"392","article-title":"Effect of pentylentetrazol (PTZ) kindling on GABAergic system: a histochemical study by staining for GABA-transaminase (GABA-T)","volume":"47","author":"Nagai","year":"1993","journal-title":"Jpn. J. Psychiatry Neurol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1152\/jn.1999.82.1.478","article-title":"NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus","volume":"82","author":"Patrylo","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib27","series-title":"The rat in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1528-1157.1994.tb02906.x","article-title":"Pentylenetetrazol-induced seizures decrease gamma-aminobutyric acid-mediated recurrent inhibition and enhance adenosine-mediated depression","volume":"35","author":"Psarropoulou","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hipo.10110","article-title":"Neuropeptide Y delays hippocampal kindling in the rat","volume":"13","author":"Reibel","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0196-9781(01)00347-3","article-title":"Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation","volume":"22","author":"Reibel","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib31","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1523\/JNEUROSCI.19-16-07230.1999","article-title":"Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation","volume":"19","author":"Sebret","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0006-2952(99)00068-4","article-title":"Reversal by flunarizine of the decrease in hippocampal acetylcholine release in pentylenetetrazole-kindled rats","volume":"58","author":"Serra","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1471-4159.1997.68010313.x","article-title":"Effect of pentylenetetrazole-induced kindling on acetylcholine release in the hippocampus of freely moving rats","volume":"68","author":"Serra","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/brain\/124.4.688","article-title":"Somatostatin- and neuropeptide Y-synthesizing neurones in the fascia dentata of humans with temporal lobe epilepsy","volume":"124","author":"Sundstrom","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(97)00677-0","article-title":"Chemical kindling induced by pentylenetetrazol changes cholecystokinin mRNA and peptide levels in rat frontal cortex","volume":"234","author":"Takeda","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-9781(01)00446-6","article-title":"Cholecystokinin\/dopamine\/GABA interactions in the nucleus accumbens: biochemical and functional correlates","volume":"22","author":"Tanganelli","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2004.12.001_bib37","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.96.11.6473","article-title":"Cholecystokinin-8 protects central cholinergic neurons against fimbria\u2013fornix lesion through the up-regulation of nerve growth factor synthesis","volume":"96","author":"Tirassa","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1568007023338978","article-title":"Cholecystokinin-8 and nerve growth factor: two endogenous molecules working for the upkeep and repair of the nervous system","volume":"1","author":"Tirassa","year":"2002","journal-title":"Curr. Drug Target CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-1656(00)00370-9","article-title":"RT-PCR ELISA method for the analysis of neurotrophin mRNA expression in brain and peripheral tissues","volume":"84","author":"Tirassa","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-4547(19970115)47:2<198::AID-JNR8>3.0.CO;2-A","article-title":"High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain","volume":"47","author":"Tirassa","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(98)01284-3","article-title":"Neuropeptide Y: emerging evidence for a functional role in seizure modulation","volume":"22","author":"Vezzani","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib42","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1523\/JNEUROSCI.21-19-07764.2001","article-title":"Genetic comparison of seizure control by norepinephrine and neuropeptide Y","volume":"21","author":"Weinshenker","year":"2001","journal-title":"J Neurosci."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0167-0115(98)00079-2","article-title":"Antiepileptic effects of NPY on pentylenetetrazole seizures","volume":"75\u201376","author":"Woldbye","year":"1998","journal-title":"Regul. Pept."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2004.12.001_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0387-7604(94)00129-4","article-title":"Molecular neurobiological approach to the pathogenesis of epilepsy: a preliminary study","volume":"17","author":"Xi-Ru","year":"1995","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0006-8993(96)01095-5","article-title":"Rats with decreased brain cholecystokinin levels show increased responsiveness to peripheral electrical stimulation-induced analgesia","volume":"745","author":"Zhang","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0169-328X(95)00230-P","article-title":"Changes in cholecystokinin mRNA expression after amygdala kindled seizures: an in situ hybridization study","volume":"35","author":"Zhang","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2004.12.001_bib47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/00001756-199208000-00012","article-title":"Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector","volume":"3","author":"Zhang","year":"1992","journal-title":"Neuroreport"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T06:25:53Z","timestamp":1549175153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839080500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S002839080500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.12.001","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}